Castleview Partners’s KraneShares MSCI All China Health Care Index ETF KURE Stock Holding History
Bought
Maintained
Sold
Other funds holding KURE
MMFA
OMC
KFA
BCV
Castleview Partners's KURE Position: Q1 2022 in Review
Castleview Partners sold out of KraneShares MSCI All China Health Care Index ETF (KURE) in Q1 2022, closing a stake of 18,540 shares — an estimated $646 sold.
Castleview Partners first reported a position in KURE in Q2 2021 and held it in 2 quarters. The position peaked at $70K in Q2 2021. 22 funds tracked by Wall St. Rank hold KURE as of Q1 2022.
- Castleview Partners reported no remaining KraneShares MSCI All China Health Care Index ETF position as of Q1 2022 after selling out during the quarter.
- Castleview Partners sold 18,540 KraneShares MSCI All China Health Care Index ETF shares in Q1 2022, an estimated $646.
- Castleview Partners first reported a position in KraneShares MSCI All China Health Care Index ETF in Q2 2021 and held it in 2 quarters.
- Castleview Partners's KraneShares MSCI All China Health Care Index ETF position peaked at $70K in Q2 2021.
- 22 funds tracked by Wall St. Rank held KraneShares MSCI All China Health Care Index ETF as of Q1 2022.
Based on Castleview Partners's 13F filing for Q1 2022, filed 16 May 2022.